PE69099A1 - Inhibidores de proteasas - Google Patents

Inhibidores de proteasas

Info

Publication number
PE69099A1
PE69099A1 PE1998000320A PE00032098A PE69099A1 PE 69099 A1 PE69099 A1 PE 69099A1 PE 1998000320 A PE1998000320 A PE 1998000320A PE 00032098 A PE00032098 A PE 00032098A PE 69099 A1 PE69099 A1 PE 69099A1
Authority
PE
Peru
Prior art keywords
alkyl
het
formula
ccero
alkynyl
Prior art date
Application number
PE1998000320A
Other languages
English (en)
Inventor
Stacie Marie Halbert
Scott Kevin Thompson
Daniel Frank Veber
Evelyne Michaud
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PE69099A1 publication Critical patent/PE69099A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UN DERIVADO DE HETEROCICLOCETOHIDRAZIDAS DE FORMULA (I), SU SAL; DONDE "L" ES ALQUILO C2-C6, Ar-ALQUILO(Ccero-C6), Het-ALQUILO(Ccero-C6), CH(R4)NR5R6, NR4R7, CH(R4)OAr`, ENTRE OTROS; Ar Y Ar' SON FENILO O NAFTILO; Het ES UN HETEROCICLO MONOCICLICO DE 5-7 MIEMBROS O BICICLICO DE 7-10 MIEMBROS SATURADO O INSATURADO CON 1-4 N, O o S; "W" ES C(O), SO2; UNO DE "X", "Y" o "Z" ES N, C=N, C=C, N=N Y LOS OTROS DOS SON CR10 o N, CON TAL QUE DOS SEAN N; R', R1, R2, R5, R8, R9, R0 Y R12 SON H, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; R3 ES ALQUILO C3-C6, Ar, Het, -CH(R17)-N(R16)-CO-R18 o UN GRUPO DE FORMULA (a), ENTRE OTROS; R4, R11 Y R15 SON H, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; R16 ES H o ALQUILO C1-C6, R17 ES ALQUILO C1-C6, ALQUENILO C2-C6 o CICLOALQUILO C3-C11; R18 ES ALQUILO C3-C6, -O-ALQUILO C3-C6, ENTRE OTROS. UN COMPUESTO PREFERIDO ES N-[2-(CIS-2,6-DIMETIL-4-MORFOLINO)TIAZOL-4-ILCARBONIL]-N'-[N-(4-PIRIDINILMETOXICARBONIL)-L-LEUCINIL]HIDRAZIDA. TAMBIEN SE REFIERE A PROCEDIMIENTOS PARA LA PREPARACION. EL COMPUESTO DE FORMULA (I) INHIBE A LA ENZIMA PROTEASA DE CISTEINA O DE SERINA, COMO CATEPSINA K, PUDIENDO SER UTIL PARA EL TRATAMIENTO DE ENFERMEDADES CARACTERIZADAS POR PERDIDA OSEA COMO OSTEOPOROSIS, PERIODONTITIS O ENFERMEDADES CARACTERIZADAS POR LA DEGRADACION EXCESIVA DEL CARTILAGO O MATRIZ
PE1998000320A 1997-04-29 1998-04-27 Inhibidores de proteasas PE69099A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4506797P 1997-04-29 1997-04-29

Publications (1)

Publication Number Publication Date
PE69099A1 true PE69099A1 (es) 1999-09-26

Family

ID=21935831

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000320A PE69099A1 (es) 1997-04-29 1998-04-27 Inhibidores de proteasas

Country Status (18)

Country Link
EP (1) EP1019046A4 (es)
JP (1) JP2002504097A (es)
KR (1) KR20010020391A (es)
CN (1) CN1261276A (es)
AR (1) AR012622A1 (es)
AU (1) AU7365198A (es)
BR (1) BR9809333A (es)
CA (1) CA2287989A1 (es)
CO (1) CO4940477A1 (es)
HU (1) HUP0001294A3 (es)
IL (1) IL132629A0 (es)
MA (1) MA26487A1 (es)
NO (1) NO995268L (es)
PE (1) PE69099A1 (es)
PL (1) PL337725A1 (es)
TR (1) TR199902703T2 (es)
WO (1) WO1998048799A1 (es)
ZA (1) ZA983522B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017219A1 (es) 1997-12-19 2001-08-22 Smithkline Beecham Corp Derivados de imidazol 1,4,5 sustituidos, composiciones que los comprenden, procedimiento para la preparacion de dichos derivados, uso de los derivados parala manufactura de un medicamento
US6100282A (en) * 1998-01-02 2000-08-08 Hoffman-La Roche Inc. Thiazole derivatives
MA26618A1 (fr) * 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
DE69914357T2 (de) 1998-11-04 2004-11-11 Smithkline Beecham Corp. Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
CO5150165A1 (es) * 1998-11-13 2002-04-29 Smithkline Beecham Plc Inhibidores de proteasa: tipo catepsina k
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
WO2001034599A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034600A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
EP1229914A4 (en) 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
US6797720B2 (en) 1999-12-03 2004-09-28 Ono Pharmaceutical Co., Ltd. 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient
WO2001040204A1 (fr) * 1999-12-03 2001-06-07 Ono Pharmaceutical Co., Ltd. Derives de 1.3.4-oxadiazoline et medicaments contenant ces derives utiles comme ingredients actifs
NZ520588A (en) 2000-03-21 2004-06-25 Smithkline Beecham Corp Protease inhibitors
WO2003062192A1 (en) 2002-01-17 2003-07-31 Smithkline Beecham Corporation Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
DE60227008D1 (de) * 2002-07-04 2008-07-17 Aventis Pharma Sa Neue thiophenacylhydrazinoderivate, verfahren zu deren herstellung, deren verwendung als arzneimittel, pharmazeutische zusammensetzungen und neue anwendungen
KR100962972B1 (ko) 2002-07-26 2010-06-09 주식회사유한양행 1-페닐피페리딘-3-온 유도체 및 그의 제조방법
WO2011015524A2 (en) * 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
KR20150046259A (ko) * 2012-08-23 2015-04-29 앨리오스 바이오파마 인크. 파라믹소바이러스 바이러스성 감염의 치료용 화합물
CN105636936B (zh) 2013-08-21 2022-04-05 詹森生物制药有限公司 抗病毒化合物
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA199800353A1 (ru) * 1995-10-30 1998-12-24 Смитклайн Бичам Корпорейшн Ингибиторы протеаз

Also Published As

Publication number Publication date
CA2287989A1 (en) 1998-11-05
PL337725A1 (en) 2000-08-28
CO4940477A1 (es) 2000-07-24
HUP0001294A3 (en) 2001-06-28
EP1019046A1 (en) 2000-07-19
IL132629A0 (en) 2001-03-19
EP1019046A4 (en) 2002-11-27
WO1998048799A1 (en) 1998-11-05
ZA983522B (en) 1998-10-29
NO995268L (no) 1999-11-15
KR20010020391A (ko) 2001-03-15
NO995268D0 (no) 1999-10-28
JP2002504097A (ja) 2002-02-05
AU7365198A (en) 1998-11-24
TR199902703T2 (xx) 2000-02-21
BR9809333A (pt) 2000-07-04
MA26487A1 (fr) 2004-12-20
CN1261276A (zh) 2000-07-26
AR012622A1 (es) 2000-11-08
HUP0001294A2 (hu) 2001-04-28

Similar Documents

Publication Publication Date Title
PE69099A1 (es) Inhibidores de proteasas
ES2103709T3 (es) Uso de inhibidores de peptidasa para la preparacion de medicamentos utiles en el tratamiento de la apoplejia.
PE20031012A1 (es) Compuesto inhibidor de la hepatitis c
PE20020566A1 (es) DERIVADOS DE FENILACETAMIDO-PIRAZOLES COMO INHIBIDORES DE LA cdk/CICLINA QUINASA
UY27357A1 (es) Nuevos agentes antidiabéticos .
DK0763049T3 (da) Nukleosid-monophosphatderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som immunundertrykkende lægemidler
PE20051136A1 (es) Derivados de sulfonamida
UY25143A1 (es) Procedimiento para la preparacion de inhibidores de proteasas.
DK0412404T3 (da) Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne
NO973035L (no) Hydroksaminsyre-holdige inhibitorer for matriks-metallproteaser
PE20010964A1 (es) Derivados de tiazolilamida
AR019641A1 (es) Una mezcla herbicida que contiene una cantidad efectiva herbicida de un derivado de benzilo 3-heterociclil sustituido, un fertilizante nitrogenado y un adyuvante, procedimiento para preparar dichas mezclas y metodo para combatir vegetacion indeseable.
CO4950562A1 (es) Inhibidores de proteasas
EA200100140A1 (ru) Терапевтическая композиция на основе флавоноидов для применения в лечении опухолей цитотоксическими агентами
PE20001052A1 (es) Inhibidores de hiv proteasa
EA200100141A1 (ru) Терапевтическая композиция на основе изофлавоноидов для применения в лечении опухолей цитотоксическими агентами
PE20001607A1 (es) 4-AMINO-4,5-DIHIDRO-BENZO[b][1,4]DIOXOCIN-3-ONA COMO INHIBIDORES DE PROTEASAS
SE8504346L (sv) N-alkyl(en)-n-(o,o-disubstituerad tiofosforyl)-n',n'-disubstituerade glycinamider, sett att framstella dessa samt akaricid, insekticid och fungicid, innehallande dess foreningar som verksam bestandsdel
PE20040996A1 (es) Derivados de aminoindazol como inhibidores de quinasas, procesos para su preparacion y composiciones farmaceuticas que los contienen
ES2059624T3 (es) Un procedimiento para preparar un peptido util como agente antihipertensivo.
AR039519A1 (es) Derivados de semicarbazida
AR008645A1 (es) MEZCLAS SoLIDAS EN BASE A UNA SAL DEL 2,2-DIoXIDO DE 3-ISOPROPIL-2,1,3- BENZOTIADIAZíN-4-ONA, uTILES PARA CONTROLAR EL CRECIMIENTO DE LAS PLANTAS INDESEADAS, PROCEDIMIENTO DE PREPARACIoN Y APLICACIoN.
SE8003246L (sv) Nytt antihypertensivt medel
AR037158A1 (es) Derivados de 2-amino-4- piridilmetil-tiazolina como inhibidores de no-sintasa inducible.
AR004401A1 (es) Derivados de la tirosina, procedimiento para prepararlos y preparaciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FC Refusal